世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Vaccine Delivery Devices Market - Global Collagen Supplements Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, By Form, By Source, By End Use, By Sales Channel, By Geographic Coverage and By Company)
The global vaccine delivery devices market is expected to witness substantial growth, reaching USD 5.90 billion in 2025 and expanding to USD 9.57 billion by 2032. Driven by increasing immunization ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global vaccine delivery devices market is expected to witness substantial growth, reaching USD 5.90 billion in 2025 and expanding to USD 9.57 billion by 2032. Driven by increasing immunization programs, government investments, and technological advancements, the market is set to expand at a compound annual growth rate (CAGR) of 7.15% over the forecast period.Market Insights The rising prevalence of infectious diseases and the growing demand for vaccines have created a heightened need for advanced vaccine delivery devices. Healthcare organizations and governments worldwide are increasing their efforts to enhance vaccination coverage, fueling the demand for innovative and efficient delivery systems. Additionally, the emergence of new infectious diseases necessitates continuous advancements in vaccine administration technology. Market Growth Drivers • Expanding Immunization Programs: The increased implementation of immunization initiatives globally is significantly driving the demand for vaccine delivery devices. As vaccination programs expand, the need for efficient and safe delivery systems increases proportionally. • Government and International Support: Governments and non-governmental organizations (NGOs) are investing heavily in healthcare infrastructure and vaccination programs, which is expected to propel market growth. • Technological Advancements: The continuous development of cutting-edge vaccine delivery methods, including needle-free injections and digital health integration, is revolutionizing the industry. • Growing Public Awareness: The increasing focus on preventive healthcare has led to higher vaccine acceptance rates, driving the need for effective delivery systems. Business Opportunities • Digital Health Integration: The incorporation of digital technologies in vaccine administration is creating new growth avenues. Real-time monitoring of immunization and compliance tracking are expected to enhance the efficiency of vaccination programs. • Needle-Free Delivery Systems: The development of jet injectors and microneedle patches presents opportunities for addressing vaccine hesitancy and improving patient compliance. • Public-Private Partnerships: Collaborations between governments and private organizations are accelerating research, development, and deployment of advanced vaccine delivery devices. • Expansion in Developing Regions: Increasing healthcare investments in Asia Pacific, Latin America, and Africa present lucrative opportunities for manufacturers. Regional Analysis • North America: The region is poised to dominate the market, supported by its advanced healthcare infrastructure, strong R&D investments, and high vaccine adoption rates. • Europe: Growing healthcare initiatives and government funding for immunization programs are driving the market in this region. • Asia Pacific: Government-backed healthcare expansion and investments in vaccine development are creating significant market growth potential. • Latin America & Middle East & Africa: Expanding vaccination campaigns and increasing access to healthcare are expected to fuel market expansion in these regions. Key Players Leading companies in the vaccine delivery devices market include: • Becton Dickinson & Company • Bioject Medical Technologies, Inc. • Inovio Pharmaceutical Inc. • PharmaJet • Vaxxas • Gerresheimer AG • SCHOTT AG • Corium International, Inc. • 3M These companies are focusing on innovation, product development, and strategic collaborations to strengthen their market presence. Recent Developments • NIAID's Clinical Trial on HIV Vaccines (March 2022): The National Institute of Allergy and Infectious Diseases (NIAID) launched a clinical trial to assess three preclinical HIV vaccines utilizing mRNA technology, marking a step forward in vaccine innovation. • Pfizer and Acuitas Partnership (January 2022): Pfizer partnered with Acuitas Therapeutics for a lipid nanoparticle delivery system for mRNA vaccines, boosting developments in mRNA-based immunization technologies. Market Segmentation The market is segmented based on device type, route of administration, and region: By Device: • Syringes • Jet Injectors • Other Devices By Route of Administration: • Intradermal • Intramuscular • Subcutaneous • Other By Region: • North America • Europe • Asia Pacific • Latin America • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Vaccine Delivery Devices Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value and Volume, 2024 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. Porter’s Five Forces Analysis 2.5. COVID-19 Impact Analysis 2.5.1. Supply 2.5.2. Demand 2.6. Economic Overview 2.6.1. World Economic Projections 2.7. PESTLE Analysis 3. Price Analysis, 2024 3.1. Global Average Price Analysis by Device, 2024 3.2. Prominent Factor Affecting Vaccine Delivery Devices Prices 3.3. Global Average Price Analysis by Region 4. Global Vaccine Delivery Devices Market Outlook, 2019 - 2032 4.1. Global Vaccine Delivery Devices Market Outlook, by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 4.1.1. Key Highlights 4.1.1.1. Syringes 4.1.1.2. Jet Injectors 4.1.1.3. Others 4.2. Global Vaccine Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 4.2.1. Key Highlights 4.2.1.1. Intradermal 4.2.1.2. Intramuscular 4.2.1.3. Subcutaneous 4.2.1.4. Others 4.3. Global Vaccine Delivery Devices Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032 4.3.1. Key Highlights 4.3.1.1. North America 4.3.1.2. Europe 4.3.1.3. Asia Pacific 4.3.1.4. Latin America 4.3.1.5. Middle East & Africa 5. North America Vaccine Delivery Devices Market Outlook, 2019 - 2032 5.1. North America Vaccine Delivery Devices Market Outlook, by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 5.1.1. Key Highlights 5.1.1.1. Syringes 5.1.1.2. Jet Injectors 5.1.1.3. Others 5.2. North America Vaccine Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 5.2.1. Key Highlights 5.2.1.1. Intradermal 5.2.1.2. Intramuscular 5.2.1.3. Subcutaneous 5.2.1.4. Others 5.2.2. Attractiveness Analysis 5.3. North America Vaccine Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032 5.3.1. Key Highlights 5.3.1.1. U.S. Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 5.3.1.2. U.S. Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 5.3.1.3. Canada Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 5.3.1.4. Canada Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 6. Europe Vaccine Delivery Devices Market Outlook, 2019 - 2032 6.1. Europe Vaccine Delivery Devices Market Outlook, by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.1.1. Key Highlights 6.1.1.1. Syringes 6.1.1.2. Jet Injectors 6.1.1.3. Others 6.2. Europe Vaccine Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.2.1. Key Highlights 6.2.1.1. Intradermal 6.2.1.2. Intramuscular 6.2.1.3. Subcutaneous 6.2.1.4. Others 6.2.2. Attractiveness Analysis 6.3. Europe Vaccine Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1. Key Highlights 6.3.1.1. Germany Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.2. Germany Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.3. U.K. Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.4. U.K. Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.5. France Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.6. France Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.7. Italy Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.8. Italy Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.9. Turkey Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.10. Turkey Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.11. Russia Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.12. Russia Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.13. Rest of Europe Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 6.3.1.14. Rest of Europe Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 7. Asia Pacific Vaccine Delivery Devices Market Outlook, 2019 - 2032 7.1. Asia Pacific Vaccine Delivery Devices Market Outlook, by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.1.1. Key Highlights 7.1.1.1. Syringes 7.1.1.2. Jet Injectors 7.1.1.3. Others 7.2. Asia Pacific Vaccine Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.2.1. Key Highlights 7.2.1.1. Intradermal 7.2.1.2. Intramuscular 7.2.1.3. Subcutaneous 7.2.1.4. Others 7.2.2. Attractiveness Analysis 7.3. Asia Pacific Vaccine Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.3.1. Key Highlights 7.3.1.1. China Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.3.1.2. China Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.3.1.3. Japan Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.3.1.4. Japan Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.3.1.5. South Korea Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.3.1.6. South Korea Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.3.1.7. India Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.3.1.8. India Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.3.1.9. Southeast Asia Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.3.1.10. Southeast Asia Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.3.1.11. Rest of Asia Pacific Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 7.3.1.12. Rest of Asia Pacific Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 8. Latin America Vaccine Delivery Devices Market Outlook, 2019 - 2032 8.1. Latin America Vaccine Delivery Devices Market Outlook, by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 8.1.1. Key Highlights 8.1.1.1. Syringes 8.1.1.2. Jet Injectors 8.1.1.3. Others 8.2. Latin America Vaccine Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 8.2.1. Key Highlights 8.2.1.1. Intradermal 8.2.1.2. Intramuscular 8.2.1.3. Subcutaneous 8.2.1.4. Others 8.2.2. Attractiveness Analysis 8.3. Latin America Vaccine Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032 8.3.1. Key Highlights 8.3.1.1. Brazil Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 8.3.1.2. Brazil Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 8.3.1.3. Mexico Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 8.3.1.4. Mexico Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 8.3.1.5. Argentina Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 8.3.1.6. Argentina Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 8.3.1.7. Rest of Latin America Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 8.3.1.8. Rest of Latin America Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 9. Middle East & Africa Vaccine Delivery Devices Market Outlook, 2019 - 2032 9.1. Middle East & Africa Vaccine Delivery Devices Market Outlook, by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 9.1.1. Key Highlights 9.1.1.1. Syringes 9.1.1.2. Jet Injectors 9.1.1.3. Others 9.2. Middle East & Africa Vaccine Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 9.2.1. Key Highlights 9.2.1.1. Intradermal 9.2.1.2. Intramuscular 9.2.1.3. Subcutaneous 9.2.1.4. Others 9.2.2. Attractiveness Analysis 9.3. Middle East & Africa Vaccine Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032 9.3.1. Key Highlights 9.3.1.1. GCC Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 9.3.1.2. GCC Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 9.3.1.3. South Africa Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 9.3.1.4. South Africa Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 9.3.1.5. Egypt Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 9.3.1.6. Egypt Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 9.3.1.7. Nigeria Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 9.3.1.8. Nigeria Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 9.3.1.9. Rest of Middle East & Africa Vaccine Delivery Devices Market by Device, Value (US$ Bn) and Volume (Units), 2019 - 2032 9.3.1.10. Rest of Middle East & Africa Vaccine Delivery Devices Market by Route of Administration, Value (US$ Bn) and Volume (Units), 2019 - 2032 10. Competitive Landscape 10.1. By Device vs by Route of Administration Heatmap 10.2. Company Market Share Analysis, 2024 10.3. Competitive Dashboard 10.4. Company Profiles 10.4.1. Becton Dickinson & Company 10.4.1.1. Company Overview 10.4.1.2. Product Portfolio 10.4.1.3. Financial Overview 10.4.1.4. Business Strategies and Development 10.4.2. Bioject Medical Technologies, Inc. 10.4.2.1. Company Overview 10.4.2.2. Product Portfolio 10.4.2.3. Financial Overview 10.4.2.4. Business Strategies and Development 10.4.3. Inovio Pharmaceutical Inc. 10.4.3.1. Company Overview 10.4.3.2. Product Portfolio 10.4.3.3. Financial Overview 10.4.3.4. Business Strategies and Development 10.4.4. PharmaJet 10.4.4.1. Company Overview 10.4.4.2. Product Portfolio 10.4.4.3. Financial Overview 10.4.4.4. Business Strategies and Development 10.4.5. Vaxxas 10.4.5.1. Company Overview 10.4.5.2. Product Portfolio 10.4.5.3. Financial Overview 10.4.5.4. Business Strategies and Development 10.4.6. Gerresheimer AG 10.4.6.1. Company Overview 10.4.6.2. Product Portfolio 10.4.6.3. Financial Overview 10.4.6.4. Business Strategies and Development 10.4.7. SCHOTT AG 10.4.7.1. Company Overview 10.4.7.2. Product Portfolio 10.4.7.3. Financial Overview 10.4.7.4. Business Strategies and Development 10.4.8. Corium International, Inc. 10.4.8.1. Company Overview 10.4.8.2. Product Portfolio 10.4.8.3. Financial Overview 10.4.8.4. Business Strategies and Development 10.4.9. 3M 10.4.9.1. Company Overview 10.4.9.2. Product Portfolio 10.4.9.3. Financial Overview 10.4.9.4. Business Strategies and Development 11. Appendix 11.1. Research Methodology 11.2. Report Assumptions 11.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（ケミカル）の最新刊レポート
Fairfield Market Research社の化学薬品・材料分野での最新刊レポート
本レポートと同じKEY WORD（vaccine）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2025/03/04 10:26 150.26 円 158.00 円 193.52 円 |
